Literature DB >> 25442866

Clinical outcomes of septic patients with diabetic ketoacidosis between 2004 and 2013 in a tertiary hospital in Taiwan.

Yu-Chen Cheng1, Chung-Hao Huang1, Wei-Ru Lin1, Po-Liang Lu2, Ko Chang3, Jih-Jin Tsai4, Kebba S Bojang5, Chun-Yu Lin6, Yen-Hsu Chen7.   

Abstract

BACKGROUND: Infection is the most common predisposing factor for diabetic ketoacidosis (DKA); however, studies are rare that have investigated the clinical outcomes of septic patients with infection-precipitated DKA.
METHODS: A retrospective cohort study was conducted at a tertiary hospital from 2004 to 2013. Patients with DKA in whom the presence of a predisposing infection was confirmed were enrolled. Characteristics at initial presentation, primary infection sources, and causative microorganisms were compared between the nonacute kidney injury (non-AKI) group and acute kidney injury (AKI) group at each stage. Risk factors for the development of failure-stage AKI and its outcomes were also analyzed.
RESULTS: One hundred and sixty DKA episodes were assessed. The most common infection sites were the urinary and respiratory tracts. The leading causative microorganism was Escherichia coli, followed by Klebsiella pneumoniae. A complicated/severe infection state [odds ratio (OR), 15.27; p < 0.001] and a high level of C-reactive protein (OR, 1.012; p < 0.001) were independently associated with bacteremia. Corrected sodium (Na; OR, 1.062; p = 0.039), initial plasma glucose (OR, 1.003; p = 0.041), severe grade of DKA (OR, 13.41; p = 0.045), and the Acute Physiology and Chronic Health Evaluation (APACHE) II score (OR, 1.08; p = 0.033) were identified as independent risk factors for the development of failure-stage AKI among septic patients with infection-precipitated DKA. Patients with failure-stage AKI had a higher frequency of incomplete recovery of renal function (20.4% of patients in failure vs. 5.9% of patients in risk and injury, p = 0.009). Bacteremia independently predicted the absence of complete recovery of renal function (OR, 5.86; p = 0.038).
CONCLUSION: For patients with infection-precipitated DKA, the clinician should aggressively monitor renal function if a patient presents with risk factors associated with failure-stage AKI. Furthermore, bacteremia predicts a poor renal prognosis.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Acute kidney injury; Diabetic ketoacidosis; End-stage kidney disease (RIFLE) classification; Failure; Injury; Loss; Risk; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25442866     DOI: 10.1016/j.jmii.2014.08.018

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  5 in total

1.  Impact of diabetes mellitus on surgical complications in patients undergoing revision total knee arthroplasty: Insulin dependence makes a difference.

Authors:  Danny Lee; Ryan Lee; Nikhil B Gowda; William V Probasco; Seth Stake; George Ibrahim; Rajeev Pandarinath
Journal:  J Clin Orthop Trauma       Date:  2019-07-17

2.  Systemic Infection Predictive Value of Procalcitonin to Lactic Acid Ratio in Diabetes Ketoacidosis Patients.

Authors:  Bin Huang; Shengju Yang; Shandong Ye
Journal:  Diabetes Metab Syndr Obes       Date:  2022-07-22       Impact factor: 3.249

Review 3.  Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review.

Authors:  Soulmaz Fazeli Farsani; Kimberly Brodovicz; Nima Soleymanlou; Jan Marquard; Erika Wissinger; Brett A Maiese
Journal:  BMJ Open       Date:  2017-08-01       Impact factor: 2.692

4.  The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications.

Authors:  Todd S Ing; Kavitha Ganta; Gautam Bhave; Susie Q Lew; Emmanuel I Agaba; Christos Argyropoulos; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2020-08-25

5.  New-onset type 1 diabetes complicated by diabetic ketoacidosis and severe sepsis requiring extracorporeal membrane oxygenation and kidney replacement therapy.

Authors:  Nurul Aliah Mohd Asarani; Justine Paddison; Robert Walker; Michelle Downie; Benjamin J Wheeler
Journal:  J Diabetes Metab Disord       Date:  2021-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.